nylidrin has been researched along with Brain Damage, Chronic in 1 studies
Nylidrin: A beta-adrenergic agonist. Nylidrin causes peripheral vasodilation, a positive inotropic effect, and increased gastric volume of gastric juice. It is used in the treatment of peripheral vascular disorders and premature labor.
Brain Damage, Chronic: A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| LEHMANN, HE | 1 |
| BAN, TA | 1 |
| KATO, G | 1 |
| GOZSY, B | 1 |
| KATO, L | 1 |
1 other study available for nylidrin and Brain Damage, Chronic
| Article | Year |
|---|---|
POTENTIATION OF PHARMACOLOGICAL AND THERAPEUTIC ACTION OF PHENOTHIAZINES BY NYLIDRIN (ARLIDIN).
Topics: Bipolar Disorder; Brain; Brain Damage, Chronic; Chlorprothixene; Depressive Disorder, Major; Dextran | 1964 |